Bruno Alves Santarossa

Secretaria da Saúde (São Paulo - Estado). Instituto Butantan (Institutional affiliation from the last research proposal)
Birthplace: Brazil

Abstract
Trypanosoma cruzi is a clinically relevant protozoan, causative agent of Chagas disease. Its endemic characteristic to emergent countries is an important contextualization to understand why it still is, proportionally to other model eukaryotes, very little understood. During its life cycle, T. cruzi transit between an invertebrate vector and a mammalian host and in these environments it p…
CRK3 (Cdc2 Related Kinase): Uncovering modulation pathways linked to cell cycle and metacyclogenesis in Trypanosoma cruzi, BP.MS
Abstract
Chagas disease is caused by Trypanosoma cruzi, an important endemic disease in tropical countries which has been considered a neglected disease by the World Health Organization (WHO). Thus, the study and understanding of this parasite are fundamental to develop new and better treatments. Gene editing by CRISPR/Cas9 together with drug resistance gene insertion has been widely used as a met…
Genetic edition and drug free selection in Trypanosoma cruzi: new methodology for modifications by CRISPR/Cas9, BP.IC

CV Lattes ORCID

2 / 2	Completed scholarships in Brazil

Associated processes